At TAPI, we believe that great things come from great partnerships. We thrive on close collaboration with our customers and are committed to providing them first-class support. Partnering together, we can help you bring your high-quality generic and innovative products to market efficiently and effectively.
Our commitment to you is expressed through four core values:
Employing more than 5,000 professionals at 19 international sites, TAPI is the leading international supplier of active pharmaceutical ingredients (APIs) with the industry’s broadest portfolio of 300 products and more than $700 million in annual third-party sales. Our leadership in cutting-edge development, large-scale production capacity and global support make TAPI your API partner of choice.
For more than 80 years, quality has been the cornerstone upon which TAPI is built, enabling us to consistently deliver top-quality products and services. Our commitment to quality is uncompromising. Our stringent policies and procedures ensure we are in full compliance with regulatory requirements, environmental standards and technological trends. Our customers can rest assured they are consistently receiving high quality, safe and effective products.
Our goal is to deliver exceptional service in every customer experience. Every interaction is an opportunity to meet and exceed your expectations. Whatever information or support you require our experts across the organization and around the world are available to assist.
At TAPI, we continually improve our practices to stay ahead. Our focus on efficiency ensures your product has the competitive edge in the global marketplace. With significant economy-of-scale advantages and back-integration capabilities, TAPI places great importance on streamlining API development, production, and product life-cycle management (PLM) processes. Our scientists are known for their expertise in: chemical synthesis, fermentation, high potency, plant extract, synthetic peptides, vitamin D derivatives, prostaglandins, analytical and solid state R&D.